Artificial intelligence in pediatric diabetes: clinical benefits, developmental risks, and ethical challenges.

Khalil H, Lynch JL, Sowan A, Ortega A, Zaitoon H.

Open source

DOI
10.1007/s00431-026-07442-z
Published
2026-09-22
Container
Eur J Pediatr
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00431-026-07442-z,
  title = {Artificial intelligence in pediatric diabetes: clinical benefits, developmental risks, and ethical challenges.},
  author = {Khalil H and  Lynch JL and  Sowan A and  Ortega A and  Zaitoon H.},
  year = {2026},
  journal = {Eur J Pediatr},
  doi = {10.1007/s00431-026-07442-z},
  url = {https://doi.org/10.1007/s00431-026-07442-z}
}

RIS

TY  - JOUR
TI  - Artificial intelligence in pediatric diabetes: clinical benefits, developmental risks, and ethical challenges.
AU  - Khalil H
AU  -  Lynch JL
AU  -  Sowan A
AU  -  Ortega A
AU  -  Zaitoon H.
PY  - 2026
JO  - Eur J Pediatr
DO  - 10.1007/s00431-026-07442-z
UR  - https://doi.org/10.1007/s00431-026-07442-z
ER  - 

APA

H, K., JL, L., A, S., A, O., & H., Z. (2026). Artificial intelligence in pediatric diabetes: clinical benefits, developmental risks, and ethical challenges.. Eur J Pediatr. https://doi.org/10.1007/s00431-026-07442-z

Source records